Pharma Foods International Co., Ltd. (2929.T)
JPY 917.0
(1.1%)
JPY 917.0
(1.1%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 | 6.71 Billion JPY | 10.97% |
| 2023 | 6.05 Billion JPY | -0.21% |
| 2022 | 6.06 Billion JPY | 120.74% |
| 2021 | 2.74 Billion JPY | 63.85% |
| 2020 | 1.67 Billion JPY | 57.5% |
| 2019 | 1.06 Billion JPY | 66.73% |
| 2018 | 638.69 Million JPY | 5.73% |
| 2017 | 604.09 Million JPY | 110.18% |
| 2016 | 287.41 Million JPY | 15.09% |
| 2015 | 249.73 Million JPY | 22.44% |
| 2014 | 203.96 Million JPY | 56.52% |
| 2013 | 130.31 Million JPY | 15.67% |
| 2012 | 112.65 Million JPY | 23.11% |
| 2011 | 91.5 Million JPY | 37.16% |
| 2010 | 66.71 Million JPY | -39.95% |
| 2009 | 111.1 Million JPY | 2.22% |
| 2008 | 108.69 Million JPY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 6.27 Billion JPY | 6.9% |
| 2024 Q4 | 6.71 Billion JPY | 7.01% |
| 2024 Q1 | 5.72 Billion JPY | -5.5% |
| 2024 Q2 | 5.87 Billion JPY | 2.66% |
| 2023 Q1 | 5.71 Billion JPY | -5.79% |
| 2023 FY | 6.05 Billion JPY | -0.21% |
| 2023 Q2 | 5.93 Billion JPY | 3.81% |
| 2023 Q3 | 6.05 Billion JPY | 2.11% |
| 2023 Q4 | 6.05 Billion JPY | -0.08% |
| 2022 FY | 6.06 Billion JPY | 120.74% |
| 2022 Q3 | 5.93 Billion JPY | 12.11% |
| 2022 Q4 | 6.06 Billion JPY | 2.26% |
| 2022 Q1 | 4.73 Billion JPY | 72.16% |
| 2022 Q2 | 5.29 Billion JPY | 11.84% |
| 2021 Q2 | 2.02 Billion JPY | 26.68% |
| 2021 Q4 | 2.74 Billion JPY | 3.68% |
| 2021 FY | 2.74 Billion JPY | 63.85% |
| 2021 Q1 | 1.59 Billion JPY | -4.61% |
| 2021 Q3 | 2.65 Billion JPY | 30.77% |
| 2020 Q3 | 1.47 Billion JPY | 27.21% |
| 2020 Q1 | 1.04 Billion JPY | -1.96% |
| 2020 FY | 1.67 Billion JPY | 57.5% |
| 2020 Q2 | 1.15 Billion JPY | 10.88% |
| 2020 Q4 | 1.67 Billion JPY | 13.89% |
| 2019 Q4 | 1.06 Billion JPY | -1.71% |
| 2019 FY | 1.06 Billion JPY | 66.73% |
| 2019 Q1 | 766.47 Million JPY | 20.01% |
| 2019 Q2 | 960.73 Million JPY | 25.34% |
| 2019 Q3 | 1.08 Billion JPY | 12.77% |
| 2018 Q1 | 564.21 Million JPY | -6.6% |
| 2018 Q3 | 504.21 Million JPY | 8.88% |
| 2018 Q2 | 463.1 Million JPY | -17.92% |
| 2018 FY | 638.69 Million JPY | 5.73% |
| 2018 Q4 | 638.69 Million JPY | 26.67% |
| 2017 Q4 | 604.09 Million JPY | -7.96% |
| 2017 FY | 604.09 Million JPY | 110.18% |
| 2017 Q1 | 330.46 Million JPY | 14.98% |
| 2017 Q2 | 538.04 Million JPY | 62.81% |
| 2017 Q3 | 656.31 Million JPY | 21.98% |
| 2016 FY | 287.41 Million JPY | 15.09% |
| 2016 Q1 | 254.75 Million JPY | 2.01% |
| 2016 Q2 | 270.41 Million JPY | 6.15% |
| 2016 Q3 | 331.19 Million JPY | 22.48% |
| 2016 Q4 | 287.41 Million JPY | -13.22% |
| 2015 Q1 | 263.85 Million JPY | 29.36% |
| 2015 Q3 | 267.6 Million JPY | 22.15% |
| 2015 Q4 | 249.73 Million JPY | -6.68% |
| 2015 Q2 | 219.08 Million JPY | -16.97% |
| 2015 FY | 249.73 Million JPY | 22.44% |
| 2014 Q2 | 145.17 Million JPY | 13.81% |
| 2014 FY | 203.96 Million JPY | 56.52% |
| 2014 Q4 | 203.96 Million JPY | 3.44% |
| 2014 Q3 | 197.17 Million JPY | 35.83% |
| 2014 Q1 | 127.55 Million JPY | -2.11% |
| 2013 Q3 | 140.98 Million JPY | -9.98% |
| 2013 Q4 | 130.31 Million JPY | -7.57% |
| 2013 FY | 130.31 Million JPY | 15.67% |
| 2013 Q1 | 116.01 Million JPY | 2.98% |
| 2013 Q2 | 156.6 Million JPY | 34.99% |
| 2012 Q3 | 113.39 Million JPY | -6.9% |
| 2012 FY | 112.65 Million JPY | 23.11% |
| 2012 Q1 | 81.98 Million JPY | -10.4% |
| 2012 Q4 | 112.65 Million JPY | -0.66% |
| 2012 Q2 | 121.8 Million JPY | 48.57% |
| 2011 Q1 | 103.59 Million JPY | 55.27% |
| 2011 Q4 | 91.5 Million JPY | -4.79% |
| 2011 FY | 91.5 Million JPY | 37.16% |
| 2011 Q3 | 96.11 Million JPY | 2.57% |
| 2011 Q2 | 93.7 Million JPY | -9.55% |
| 2010 Q1 | 96.65 Million JPY | -13.01% |
| 2010 Q3 | 88.71 Million JPY | -1.77% |
| 2010 FY | 66.71 Million JPY | -39.95% |
| 2010 Q4 | 66.71 Million JPY | -24.8% |
| 2010 Q2 | 90.31 Million JPY | -6.55% |
| 2009 Q3 | 121.59 Million JPY | 13.79% |
| 2009 Q2 | 106.86 Million JPY | 0.0% |
| 2009 Q4 | 111.1 Million JPY | -8.62% |
| 2009 FY | 111.1 Million JPY | 2.22% |
| 2008 FY | 108.69 Million JPY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Takeda Pharmaceutical Company Limited | 1209.86 Billion JPY | 99.445% |
| Sumitomo Pharma Co., Ltd. | 115.35 Billion JPY | 94.177% |
| Shionogi & Co., Ltd. | 64.91 Billion JPY | 89.653% |
| Wakamoto Pharmaceutical Co.,Ltd. | 2 Billion JPY | -234.84% |
| Nippon Shinyaku Co., Ltd. | 39.11 Billion JPY | 82.826% |
| Kaken Pharmaceutical Co., Ltd. | 17.16 Billion JPY | 60.873% |
| Eisai Co., Ltd. | 174.65 Billion JPY | 96.154% |
| Morishita Jintan Co., Ltd. | 3.18 Billion JPY | -110.895% |
| Hisamitsu Pharmaceutical Co., Inc. | 21.17 Billion JPY | 68.28% |
| Mochida Pharmaceutical Co., Ltd. | 30.27 Billion JPY | 77.816% |
| Fuso Pharmaceutical Industries,Ltd. | 14.2 Billion JPY | 52.704% |
| Nippon Chemiphar Co., Ltd. | 10.72 Billion JPY | 37.353% |
| Tsumura & Co. | 117.61 Billion JPY | 94.289% |
| Kissei Pharmaceutical Co., Ltd. | 26.29 Billion JPY | 74.456% |
| Torii Pharmaceutical Co., Ltd. | 10.74 Billion JPY | 37.47% |
| Towa Pharmaceutical Co., Ltd. | 101.07 Billion JPY | 93.354% |
| Fuji Pharma Co., Ltd. | 19.37 Billion JPY | 65.324% |
| Zeria Pharmaceutical Co., Ltd. | 14.48 Billion JPY | 53.643% |
| KYORIN Holdings, Inc. | 53.47 Billion JPY | 87.438% |
| Taiko Pharmaceutical Co.,Ltd. | 1.95 Billion JPY | -244.109% |
| Daito Pharmaceutical Co.,Ltd. | 20.89 Billion JPY | 67.846% |
| SymBio Pharmaceuticals Limited | 232.03 Million JPY | -2794.884% |
| MedRx Co., Ltd | 10 Million JPY | -67070.0% |
| Mizuho Medy Co.,Ltd. | 1.59 Billion JPY | -320.704% |
| Solasia Pharma K.K. | 122 Million JPY | -5405.738% |
| Modalis Therapeutics Corporation | 6.35 Million JPY | -105629.577% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 20.4 Billion JPY | 67.077% |
| Sawai Group Holdings Co., Ltd. | 100 Billion JPY | 93.283% |
| Cyfuse Biomedical K.K. | 46.04 Million JPY | -14487.903% |
| Toho Holdings Co., Ltd. | 87.28 Billion JPY | 92.305% |
| Koa Shoji Holdings Co.,Ltd. | 2.26 Billion JPY | -196.392% |